Neuberger Berman High Yield Strategies Fund Return on Equity

Neuberger Berman High Yield Strategies Fund (NHS) currently reports a ROE of 13.81%. That is above the sector sector average of -5.68%. Use the charts on this page to explore Neuberger Berman High Yield Strategies Fund's ROE history and peer comparisons.

Neuberger Berman High Yield Strategies Fund's ROE of 13.81% is higher than the its sector sector average of -5.68%. That is roughly 343.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Neuberger Berman High Yield Strategies Fund's current 13.81% should be judged against industry norms (sector average: -5.68%) and against NHS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 13.81%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for Neuberger Berman High Yield Strategies Fund, and consider following NHS for alerts when major investors trade the stock.